Login / Signup

Burst Release from In Situ Forming PLGA-Based Implants: 12 Effectors and Ways of Correction.

Bakhrushina E OPolina S SakharovaPolina D KonogorovaVictor S PyzhovSvetlana I KosenkovaAlexander I BardakovIrina M ZubarevaIvan I KrasnyukKrasnyuk I I Jr
Published in: Pharmaceutics (2024)
The analysis resulted in development of a systematic approach called the "12 Factor System", which considers various constant and variable, endogenous and exogenous factors that can influence the nature of 'burst release' of active ingredients from PLGA polymer-based in situ formed implants. These factors include matrix porosity, polymer swelling, LA:GA ratio, PLGA end groups, polymer molecular weight, active ingredient structure, polymer concentration, polymer loading with active ingredients, polymer combination, use of co-solvents, addition of excipients, and change of dissolution conditions. This review also considered different types of kinetics of active ingredient release from in situ formed implants and the possibility of using the "burst release" phenomenon to modify the active ingredient release profile at the site of application of this dosage form.
Keyphrases
  • drug delivery
  • high frequency
  • drug release
  • soft tissue